Malathion dermal permeability in relation to dermal load: Assessment by physiologically based pharmacokinetic modeling of in vivo human data

References

• Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for malathion, September 2003. Atlanta, GA, 2003. Available at http://www.atsdr.cdc.gov/toxprofiles/tp154.pdf. (accessed Jul 2016).
   Google Scholar
• International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 112: Some Organophosphate Insecticides and Herbicides: Diazinon, Glyphosate, Malathion, Parathion, and Tetrachlorvinphos. IARC: Lyon, France, 2015; 1–124. Available at http://monographs.iarc.fr/ENG/Monographs/vol112/mono112-07.pdf. (accessed Jul 2016).
   Google Scholar
• U.S. Environmental Protection Agency (EPA). Registration Eligibility Decision (RED) for Malathion. Revised May 2009 EPA 738-R-06-030, July 2016, U.S. EPA Office of Prevention, Pesticides and Toxic Substances: Washington, DC, 2006.
   Google Scholar
• U.S. Environmental Protection Agency (EPA). Reregistration Eligibility Decision (RED) for Malathion. Case No. 0248, EPA 738-R-06-030. U.S. EPA Office of Prevention, Pesticides and Toxic Substances: Washington, DC, 2009. Availalbe at https://archive.epa.gov/pesticides/reregistration/web/pdf/malathion-red-revised.pdf. (accessed Jul 2016).
   Google Scholar
• California Department of Health Services (CalDHS). Health Risk Assessment of Aerial Application of Malathion-Bait. CalDHS: Berkeley, CA, 1991.
   Google Scholar
• California Department of Pesticide Regulation (CalDPR). Malathion Dietary Exposure Assessment. Technical Report by Hathaway TR, Carr WC, February 4, 1993; CalDPR Medical Toxicology Branch: Sacramento, CA, 1993. Available at http://www.cdpr.ca.gov/docs/risk/rcd/mala_ab2161.pdf. (accessed Jul 2016).
   Google Scholar
• California Department of Pesticide Regulation (CalDPR). Physiologically-Based Pharmacokinetic (PB-PK) Modeling for Dermal Absorption of Pesticide (Malathion) in Man, Technical Report HS–1678, by Dong MH, Ross JH, Thongsinthusak T, Sanborn JR, Wang RGM; California Department of Pesticide Regulation (CalDPR). Worker Health and Safety Branch: Sacramento, CA, 1996.
   Google Scholar
• Machera, K.; Goumenou, M.; Kapetanakis, E.; Kalamarakis, A.; Glass, C.R. Determination of potential dermal and inhalation operator exposure to malathion in greenhouses with the whole body dosimetry method. Ann. Occup. Hyg. 2003, 47(1), 61–70.
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency (EPA). Malathion Exposure During Lice Treatment: Use of Exposure Related Dose Estimating Model (ERDEM) and Factors Relating to the Evaluation of Risk Report by Power FW, Dary CC, Knaak JB, Tornero-Velez R, Blancato JN. EPA/600/R-07/023, NTIS PB2007-106971. U.S. EPA, Office of Research and Development, National Exposure Research Laboratory: Las Vegas, NV, 2007.
   Google Scholar
• U.S. Environmental Protection Agency (EPA). Acute Exposure Guideline Levels (AEGLs) for Malathion (CAS Reg. No. 121-75-5), Interim. Interim: 09/2009. U.S. EPA, Office of Pollution Prevention and Toxics: Washington, DC, 2009. Available at https://www.epa.gov/sites/production/files/2014-08/documents/malathion_interim_sep_09_v1.pdf ( accessed Jul 2016).
   Google Scholar
• Krieger, R.I.; Bernard, C.E.; Dinoff, T.M.; Fell, L.; Osimitz, T.G.; Ross, J.H.; Thongsinthusak, T. Biomonitoring and whole body cotton dosimetry to estimate potential human dermal exposure to semivolatile chemicals. J. Expos. Anal. Environ. Epidemiol. 2000, 10, 50–57.
   PubMedGoogle Scholar
• Tuomainen, A.; Kangas, J.A., Meuling, W.J, Glass, R.C. Monitoring of pesticide applicators for potential dermal exposure to malathion and biomarkers in urine. Toxicol. Lett. 2002, 134(1–3), 125–132.
   PubMed Web of Science ®Google Scholar
• Edwards, J.W.; Lee, S.G.; Heath, L.M.; Pisaniello, D.L. Worker exposure and a risk assessment of malathion and fenthion used in the control of Mediterranean fruit fly in South Australia. Environ. Res. 2007, 103(1), 38–45.
   PubMed Web of Science ®Google Scholar
• Li, Y.; Chen, L.; Chen, Z.; Coehlo, J.; Cui, L.; Liu, Y.; Lopez, T.; Sankaran, G.; Vega, H.; Krieger, R. Glove accumulation of pesticide residues for strawberry harvester exposure assessment. Bull. Environ. Contam. Toxicol. 2011, 86(6), 615–620.
   PubMed Web of Science ®Google Scholar
• Wester, R.C.; Maibach, H.I.; Bucks, D.A.W.; Guy, R.H. Malathion percutaneous absorption after repeated administration to man. Toxicol. Appl. Pharmacol. 1983, 68, 116–119.
   PubMed Web of Science ®Google Scholar
• U.S. EPA. Dermal Exposure Assessment: Principles and Applications. EPA 600/8–91-/011-B January 1992, Interim Report; U.S. Environmental Protection Agency (EPA), Office of Health and Environmental Assessment: Washington, DC, 1992.
   Google Scholar
• Poet, T.S. Assessing dermal absorption. Toxicol. Sci. 2000, 58(1), 1–2.
   PubMed Web of Science ®Google Scholar
• International Programme on Chemical Safety (IPCS). Environmental Health Criteria 235: Dermal Absorption. World Health Organization (WHO). IPCS: Geneva, 2006, 35–37, 70-72, 109, 125. Available at http://www.inchem.org/documents/ehc/ehc/ehc235.pdf (accessed Jul 2016).
   Google Scholar
• Holmgaard, R.; Nielsen, J.B. Dermal Absorption of Pesticides – Evaluation of Variability and Prevention, Pesticides Research No. 124 2009; Danish Environmental Protection Agency: Copenhagen, Denmark, 2009. Available at http://www2.mst.dk/udgiv/publications/2009/978-87-7052-980-8/pdf/978-87-7052-981-5.pdf. (accessed Jul 2016).
   Google Scholar
• Dary, C.C.; Blancato, J.N.; Castles, M.; Reddy, V.; Cannon, M.; Saleh, M.A.; Cash, G.G. Dermal absorption and disposition of formulations of malathion in Sprague-Dawley rats and humans. In Biomarkers of Human Exposure to Pesticides (ACS Symp Ser 542, Chapter 15); Saleh, M.A.; Blancato, J.N.; Nauman, C.H., Eds.; American Chemical Society: Washington, DC, 1993; 231–263.
   Google Scholar
• Rabovsky, J.; Brown, J.P. Malathion metabolism and disposition in mammals. J. Occup. Med. Toxicol. 1993, 2(1), 131–168.
   Google Scholar
• Dong, M.H. Microcomputer programs for physiologically-based pharmacokinetic (PB-PK) modeling. Comput. Meth. Prog. Biomed. 1994, 45, 213–221.
   PubMed Web of Science ®Google Scholar
• Dong, M.H.; Draper, W.M.; Papanek, P.J.; Ross, J.H.; Woloshin, K.A.; Stephens, R.D. Estimating malathion doses in California's medfly eradication campaign using a physiologically based pharmacokinetic model. In Environmental Epidemiology (Adv Chem Ser 241, Chapter 14); Draper, W.M., Ed.; American Chemistry Society; Washington, DC, 1994, 189–208.
   Google Scholar
• Dong, M.H.; Thongsinthusak, T.; Ross, J.H.; Krieger, R.I. Validation of a physiologically-based pharmacokinetic (PB-PK) model used to simulate absorbed malathion doses in humans. 209th ACS National Meeting, American Chemistry Society, Anaheim, CA, April 2–6, 1995, S 209 (Abrastact 065).
   Google Scholar
• Dong, M.H.; Ross, J.H.; Thongsinthusak, T.; Krieger, R.I. Use of spot urine sample results in physiologically based pharmacokinetic modeling of absorbed malathion doses in humans. In Biomarkers for Agrochemicals and Toxic Substances: Applications and Risk Assessment (ACS Symp. Ser. 643, Chapter 17) Blancato, J.N.; Brown, R.N.; Dary, C.C.; Saleh, M.A., Eds.; American Chemical Society: Washington, DC, 1996; 229–243.
   Google Scholar
• Bouchard, M.; Gosselin, N.H.; Brunet, R.C.; Samuel, O.; Dumoulin, M.J.; Carrier, G. A toxicokinetic model of malathion and its metabolites as a tool to assess human exposure and risk through measurements of urinary biomarkers. Toxicol. Sci. 2003, 73(1), 182–194.
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency (EPA). Dermal Exposure Assessment: A Summary of EPA Approaches. EPA 600/R-07/040F. U.S. EPA, National Center for Environmental Assessment, Office of Research and Development: Washington, DC, 2007.
   Google Scholar
• Frasch, H.F.; Dotson, G.S.; Bunge, A.L.; Chen, C-P.; Cherrie, J.W.; Kasting, G.B.; Kissel, J.C.; Sahmel, J.; Semple, S.; Wilkinson, S. Analysis of finite dose dermal absorption data: Implications for dermal exposure assessment. J. Expos. Sci. Environ. Epidemiol. 2014, 24, 65–73.
   PubMed Web of Science ®Google Scholar
• Aston, L.S. Determination of Residues of Malathion Dicarboxylic Acid (DCA), Malathion Monocarboxylic Acid (MCA), Dimethyl Phosphate (DMP), Dimethyl Thiophosphate (DMTP), and Dimethyl Dithiophosphate (DMDTP) in Human Urine. Project ID PTL119801. Pacific Toxicology Laboratories (PTL): Woodland Hills, CA, 2000.
   Google Scholar
• Wolfram Research. Wolfram Mathematica® 10.3 Wolfram Language and System Documentation Center www.wolfram.com. Wolfram Research, Inc.: Champaign, IL, 2016. Available at http://reference.wolfram.com/language/. (accessed Jul 2016).
   Google Scholar
• Rachadi, T. Locust Control Handbook: Guide Practique. Center for Rural and Agricultural Cooperation (CTA). Éditions Quæ: Versailles, France, 2010, 35. Available at http://publications.cta.int/media/publications/downloads/1613_PDF.pdf. (accessed Jul 2016).
   Google Scholar
• Rosenberg, A.; Williams, R.; Cohen, G. Interaction forces involved in wetting of human skin. J. Pharmaceut. Sci. 1973, 62(6), 920–922.
   PubMed Web of Science ®Google Scholar
• Tsutsumi, H.; Utsugi, T.; Hayashi, S. Study on the occlusivity of oil films. J. Soc. Cosmet. Chem. 1979, 30, 345–356.
   Web of Science ®Google Scholar
• Teichman, A.; Paissavini, M.; Ferrero, L.; Dehais, A.; Zastrow, L. Investigation of the homogeneity of the distribution of sunscreen formulations on the human skin: characterization and comparison of two different methods. J. Biomed. Opt. 2006, 11(6), 064005 (November/December 2006). Available at http://biblioscreen.helioscreen.fr/Documents%20helioscreen/JBO2006.pdf. (accessed Jul 2016).
   Web of Science ®Google Scholar
• Weigmann, H-J.; Schanzer, S.; Vergou, T.; Antoniou, C.; Sterry, W.; Lademann, J. Quantification of the inhomogeneous distribution of topically applied substances by optical spectroscopy: definition of a factor of inhomogeneity. Skin Pharmacol. Physiol. 2012, 25, 118–123.
   PubMed Web of Science ®Google Scholar
• Boutsiouki, P.; Clough, G.F. Modulation of microvascular function following low-dose exposure to the organophosphorous compound malathion in human skin in vivo. J. Appl. Physiol. 2004, 97(3), 1091–1097.
   PubMed Web of Science ®Google Scholar
• Boutsiouki, P.; Thompson, J.P.; Clough, G.F. Effects of local blood flow on the percutaneous absorption of the organophosphorus compound malathion: a microdialysis study in man. Arch. Toxicol. 2001, 75(6), 321–328.
   PubMed Web of Science ®Google Scholar
• Boutsiouki, P.; Georgiou, S.; Clough, G.F. Recovery of nitric oxide from acetylcholine-mediated vasodilatation in human skin in vivo. Microcirculation 2004, 11(3), 249–259.
   PubMed Web of Science ®Google Scholar
• Hammarlund, A.; Olsson, P.; Pipkorn, U. Dermal blood flow after local challenges with allergen, histamine, bradykinin and compound 48/80. Clin. Exp. Allergy 1991, 21(3), 333–342.
   PubMed Web of Science ®Google Scholar
• Van der Schueren, B.J.; de Hoon, J.N.; Vanmolkot, F.H.; Van Hecken, A.; Depre, M.; Kane, S.A.; De Lepeleire, I.; Sinclair, S.R. Reproducibility of the capsaicin-induced dermal blood flow response as assessed by laser Doppler perfusion imaging. Br. J. Clin. Pharmacol. 2007, 64(5), 580–590.
   PubMed Web of Science ®Google Scholar
• Khambam, S.K.R.; Naidu, M.U.R.; Rani, P.U.; Rao, T.R.K. Determination of capsaicin induced increase in dermal blood flow using laser doppler flowmetry technique. Pharmacol. Pharm. 2011, 2, 159–163.
   Google Scholar
• Nielsen, T.A.; da Silva, L.B.; Arendt-Nielsen, L.; Gazerani, P. The effect of topical capsaicin-induced sensitization on heat-evoked cutaneous vasomotor responses. Int. J. Physiol. Pathophysiol. Pharmacol. 2013, 5(3), 148–160.
   PubMedGoogle Scholar
• Gordon, S.M.; Wallace, L.A.; Callahan, P.J.; Kenny, D.V.; Brinkman, M.C. Effect of water temperature on dermal exposure to chloroform. Environ. Health Perspect. 1998, 106(6), 337–345.
   PubMed Web of Science ®Google Scholar
• Corley, R.A.; Gordon, S.M.; Wallace, L.A. Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures. Toxicol. Sci. 2000, 53(1), 13–23.
   PubMed Web of Science ®Google Scholar
• Hull, W. Heat-enhanced transdermal drug delivery: A survey paper. J. Appl. Res. Clin. Exp. Therap. 2002, 2, 1–9.
   Google Scholar
• Petersen, K.K.; Rousing, M.L.; Jensen, C.; Arendt-Nielsen, L.; Gazerani, P. Effect of local controlled heat on transdermal delivery of nicotine. Int. J. Physiol. Pathophysiol. Pharmacol. 2011, 3(3), 236–242.
   PubMedGoogle Scholar
• Oliveira, G.; Leverett, J.C.; Emamzadeh, M.; Lane, M.E. The effects of heat on skin barrier function and in vivo dermal absorption. Int. J. Pharm. 2014, 464(1–2), 145–151.
   PubMed Web of Science ®Google Scholar
• Nicolau, G.; Baughman, R.A.; Tonelli, A.; McWilliams, W.; Schiltz, J.; Yacobi, A. Deposition of viprostol (a synthetic PGE2 vasodilator) in the skin following topical administration to laboratory animals. Xenobiotica 1987, 17(9), 1113–1120.
   PubMed Web of Science ®Google Scholar
• Tur, E.; Maibach, H.I.; Guy, R.H. Percutaneous penetration of methyl nicotinate at three anatomic sites: Evidence for an appendageal contribution to transport? Skin Pharmacol. 1991, 4(4), 230–234.
   PubMedGoogle Scholar
• Otberg, N.; Patzelt, A.; Rasulev, U.; Hagemeister, T.; Linscheid, M.; Sinkgraven, R.; Sterry, W.; Lademann, J. The role of hair follicles in the percutaneous absorption of caffeine. Br. J. Clin. Pharmacol. 2008; 65(4), 488–492.
   PubMed Web of Science ®Google Scholar
• Liu, X.; Grice, J.E.; Lademann, J.; Otberg, N.; Trauer, S.; Patzelt, A.; Roberts, M.S. Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man. Br. J. Clin. Pharmacol. 2011, 72(5), 768–774.
   PubMed Web of Science ®Google Scholar
• Nayak, A.P.; Hettick, J.M.; Siegel, P.D.; Anderson, S.E.; Long, C.M.; Green, B.J, Beezhold, D.H. Toluene diisocyanate (TDI) disposition and co-localization of immune cells in hair follicles. Toxicol. Sci. 2014, 140(2), 327–337.
   PubMed Web of Science ®Google Scholar
• Botchkarev, V.A. Stress and the hair follicle: Exploring the connections. Am. J. Pathol. 2003, 162(3), 709–712.
   PubMed Web of Science ®Google Scholar
• Premkumar, L.S.; Sikand, P. TRPV1: A target for next generation analgesics. Curr. Neuropharmacol. 2008, 6(2), 151–163.
   PubMed Web of Science ®Google Scholar
• Abraham, T.S.; Chen, M.L.; Ma, S.X. TRPV1 expression in acupuncture points: Response to electroacupuncture stimulation. J. Chem. Neuroanat. 2011, 41(3), 129–236.
   PubMed Web of Science ®Google Scholar
• Wang, N.; Gibbons, C.H.; Freeman, R. Novel immunohistochemical techniques using discrete signal amplification systems for human cutaneous peripheral nerve fiber imaging. J. Histochem. Cytochem. 2011, 59(4), 382–390.
   PubMed Web of Science ®Google Scholar
• Knaak, J.B.; Dary, C.C.; Power, F.; Thompson, C.B.; Blancato, J.N. Physicochemical and biological data for the development of predictive organophosphorus pesticide QSARs and PBPK/PD models for human risk assessment. Crit. Rev. Toxicol. 2004, 34(2), 143–207.
   PubMed Web of Science ®Google Scholar
• Buratti, F.M.; Testai, E. Malathion detoxification by human hepatic carboxylesterases and its inhibition by isomalathion and other pesticides. J. Biochem. Mol. Toxicol. 2005, 19(6), 406–414.
   PubMed Web of Science ®Google Scholar
• California Environmental Protection Agency (CalEPA). Health Risk Assessment of Malathion Coproducts in Malathion-Bait Used for Agricultural Pest Eradication in Urban Areas—Supplemental to: Health Risk Assessment of Aerial Application of Malathion-Bait. CalEPA Office of Environmental Health Hazard Assessment (OEHHA): Sacramento, CA, 1997. Available at http://www.oehha.org/pesticides/pdf/malaco97.pdf. (accessed Jul 2016).
   Google Scholar
• Jellinek, Schwartz, and Connolly, Inc. The Effects and Pharmacological Disposition of a Single Oral Dose of Malathion Administered to Human Volunteers. CHA Doc. No.: 299 FYF Amdt-4. Submitted to EPA on 5/17/00, MRID 45125601. Cheminova: Lemvig, Denmark, 2000. (As cited by Bouchard et al.[26])
   Google Scholar
• U.S. Army Chemical Materials Agency. Characteristics of Nerve Agents: Fact Sheet. Aberdeen Proving Ground: Aberdeen, MD, 2007. Available at http://www.cma.army.mil/fndocumentviewer.aspx?docid=003676623. (accessed Jul 2016).
   Google Scholar
• Rosenblatt, D.H.; Small, M.J.; Kimmell, T.A.; Anderson, A.W. Background Chemistry for Chemical Warfare Agents and Decontamination Processes in Support of Delisting Waste Streams at the U.S. Army Dugway Proving Ground, Utah. ANL/EAD/TM-56. Argonne National Laboratory (ANL), Environmental Assessment Division: Argonne, IL, 1996. Available at http://www.osti.gov/scitech/servlets/purl/258187/. (accessed Jul 2016).
   Google Scholar
• Hisatake, K.; Tanaka, S.; Aizawa, Y. Evaporation rate of water in a vessel. J. Appl. Phys. 1993, 73, 7395–7401.
   Web of Science ®Google Scholar